<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">jsms</journal-id><journal-title-group><journal-title xml:lang="ru">Journal of Siberian Medical Sciences</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of Siberian Medical Sciences</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2542-1174</issn><publisher><publisher-name>Federal state budgetary educational institution of higher education "Novosibirsk state medical university" of  Ministry of Health of the Russian Federation (FSBEI HE NSMU MOH Russia)</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">jsms-462</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title></article-title><trans-title-group xml:lang="en"><trans-title>Assessment of efficiency and the safety of Ovariamin® drug in normalization of menstrual cycle</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Sokolova</surname><given-names>T. M.</given-names></name></name-alternatives><email xlink:type="simple">tatyana3965@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Marinkin</surname><given-names>I. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Kiseleva</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Kuleshov</surname><given-names>V. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Makarov</surname><given-names>K. Ju.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Khayatova</surname><given-names>Z. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Jakimova</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Usova</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="en" id="aff-1"><institution>Novosibirsk State Medical University</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>04</day><month>06</month><year>2018</year></pub-date><volume>0</volume><issue>2</issue><fpage>10</fpage><lpage>13</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Sokolova T.M., Marinkin I.O., Kiseleva T.V., Kuleshov V.M., Makarov K.J., Khayatova Z.B., Jakimova A.V., Usova A.V., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Sokolova T.M., Marinkin I.O., Kiseleva T.V., Kuleshov V.M., Makarov K.J., Khayatova Z.B., Jakimova A.V., Usova A.V.</copyright-holder><copyright-holder xml:lang="en">Sokolova T.M., Marinkin I.O., Kiseleva T.V., Kuleshov V.M., Makarov K.J., Khayatova Z.B., Jakimova A.V., Usova A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://jsms.elpub.ru/jour/article/view/462">https://jsms.elpub.ru/jour/article/view/462</self-uri><trans-abstract xml:lang="en"><p>We performed an open controlled trial of efficiency and the safety of Ovariamin® drug in treatment of menstrual disorders. The research included 33 patients with menstrual disorder which were divided into 2 groups: the 1st group - menstrual disorders /ICD10/N91. The absent scanty and infrequent menstruation (n = 17); the 2nd group - menstrual disorders /ICD10/ N92. Abundant, frequent and irregular menstruations (n = 16). The analysis of clinical efficiency of administration of Ovariamin® drug in 3 months showed the following: normalization of menstrual cycle in the 1st group was registered in 52.9% of patients, in the 2nd group - in 62.5%; decrease of menstrual pain was registered in 52.9% in the 1st group and in 62.5% in the 2nd group. Satisfaction of patients in the end of the therapy was revealed in 88.2% in the 1st group, and in 93.8% in the 2nd group respectively; efficiency in maintenance of regular menstrual cycle in the next 6 months after treatment was revealed in 76.5% of patients of the 1st group, and in 75% of the 2nd group of patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Ovariamin®</kwd><kwd>Menstrual cycle</kwd><kwd>Menstruation</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ginekologija. Nacional’noeRukovodstvo (2009). Moscow: GjeotarMedia.</mixed-citation><mixed-citation xml:lang="en">Ginekologija. Nacional’noeRukovodstvo (2009). Moscow: GjeotarMedia.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ovariamin® Prescribing Information (consumer information).</mixed-citation><mixed-citation xml:lang="en">Ovariamin® Prescribing Information (consumer information).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznecova I.V., Sheveleva T.V. (2013). The effectiveness of vitaminvegetative complex in the treatment of menstrual disorder in young women. Gynecology, 2, 12-19.</mixed-citation><mixed-citation xml:lang="en">Kuznecova I.V., Sheveleva T.V. (2013). The effectiveness of vitaminvegetative complex in the treatment of menstrual disorder in young women. Gynecology, 2, 12-19.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Matteson K.A., Raker C.A., Clark M.A., Frick K.D. (2013). Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the Medical Expenditures Panel Survey. J Womens Health (Larchmt), 22, 959-965.</mixed-citation><mixed-citation xml:lang="en">Matteson K.A., Raker C.A., Clark M.A., Frick K.D. (2013). Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the Medical Expenditures Panel Survey. J Womens Health (Larchmt), 22, 959-965.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">World Medical Association (WMA). WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. (2013). Retrieved Jule 3, 2015 from http://www.wma.net/en/30publications/10policies/b3/index.html.pdf?printmediatype&amp;footerright¼[page]/[toPage].</mixed-citation><mixed-citation xml:lang="en">World Medical Association (WMA). WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. (2013). Retrieved Jule 3, 2015 from http://www.wma.net/en/30publications/10policies/b3/index.html.pdf?printmediatype&amp;footerright¼[page]/[toPage].</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">The order of the Ministry of Health of the RF “On approval of Rules of clinical practice in the Russian Federation” of June 19, 2003 No. 266 (Dokipediya: The order of the Ministry of Health of the RF “On approval of Rules of clinical practice in the Russian Federation” of June 19, 2003 N 266”).</mixed-citation><mixed-citation xml:lang="en">The order of the Ministry of Health of the RF “On approval of Rules of clinical practice in the Russian Federation” of June 19, 2003 No. 266 (Dokipediya: The order of the Ministry of Health of the RF “On approval of Rules of clinical practice in the Russian Federation” of June 19, 2003 N 266”).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
